Transcription Factors as Novel Therapeutic Targets and Drivers of Prostate Cancer Progression

Prostate cancer is the second most diagnosed cancer among men worldwide. Androgen deprivation therapy, the most common targeted therapeutic option, is circumvented as prostate cancer progresses from androgen dependent to castrate-resistant disease. Whilst the nuclear receptor transcription factor, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Kangzhe, Tan, Keely, Naylor, Matthew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082354/
https://www.ncbi.nlm.nih.gov/pubmed/35547880
http://dx.doi.org/10.3389/fonc.2022.854151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082354/
https://www.ncbi.nlm.nih.gov/pubmed/35547880
http://dx.doi.org/10.3389/fonc.2022.854151

Ejemplares similares